A composition for treating animal endometritis

A technology of endometritis and composition, which is applied in the direction of drug combination, anti-inflammatory agents, diseases, etc., can solve the problems of affecting the export of dairy products, adverse health effects, high cost of antibiotics, etc., and achieves fast onset and long duration , good therapeutic effect

Inactive Publication Date: 2003-12-31
BEIJING LISHIDA PHARMA
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the past, antibiotics were mostly used in the treatment of endometritis, but the cost of antibiotics is high, and after being absorbed by the body, they will remain in the body, especially in cow's milk, which will have adverse effects on human health and affect other export of dairy products

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Embodiment 1: 4.2 grams of chlorhexidine acetate, 17 grams of camphor, and 79 grams of vegetable oil. Sterilize the oil at 150°C for 30 minutes. When the temperature of the oil drops to 50°C, add camphor fine powder, stir to melt completely, filter with nylon cloth, add chlorhexidine acetate to the above oil solution, stir well, pass through the colloid Grind it 3-4 times. Filled into a suspension of 24g / support,

[0017] 5. Summary of clinical efficacy

[0018] (1) Test drug Chlorhexidine acetate suspension prepared according to the method in the examples, lot number 960701.

[0019] 187 dairy cows with natural disease and confirmed by veterinarians as endometritis.

[0020] (2) Diagnostic criteria:

[0021] A. Cataract type - rectal examination uterine horn and uterine body wall thickening, or inconsistent thickness, soft, mild contraction response. Vaginal examination showed that the cervix was slightly dilated, and 1-2 fingers could be inserted. During estrus,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to veterinary medicine prepared with chlorhexidinum and camphor for treating animal endometritis. Clinical observation shows its relatively high treating effect.

Description

1. Technical field [0001] The invention relates to a composition for treating animal endometritis, which has the functions of reducing inflammation, strengthening uterine contraction, improving blood supply, regulating and exciting the secretion of uterine glands, and promoting the purification of uterine cavity. 2. Background technology [0002] Infertility is the enemy of the animal husbandry industry, and the one with the highest incidence and the greatest harm is chronic endometritis, which often leads to premature elimination of dairy cows in the dairy industry. With the rapid development of animal husbandry, the incidence of endometritis has also increased significantly, and a large number of breeding animals have repeatedly been infertile, which has seriously affected the development of animal husbandry. In the past, antibiotics were mostly used in the treatment of endometritis, but the cost of antibiotics is high, and after being absorbed by the body, they will remai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/155A61P15/00A61P29/00
Inventor 赵振明
Owner BEIJING LISHIDA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap